local_hospital

Centre Hospitalier Universitaire de la Guadeloupe

Address
lock Available on a paid plan

Critical Care and Hematology

At Centre Hospitalier Universitaire de la Guadeloupe, clinical research in the Intensive Care Unit focuses on severe hemophagocytic lymphohistiocytosis, a rare and life-threatening condition that can cause rapid organ dysfunction. The trials are designed to better understand how treatment timing may influence patient outcomes in critical illness.

  • Evaluating how different approaches to starting etoposide may affect the course of organ failure in severe HLH
  • Studying whether earlier treatment can improve recovery compared with waiting for signs of worsening

This research at the Guadeloupe site is aimed at improving treatment decisions for critically ill patients by clarifying the best time to begin therapy.

Rare Disease Care in Intensive Medicine

The site is also contributing to research on the management of severe HLH in critical care, with a strong focus on organ protection and treatment effectiveness. These studies seek to refine care for a complex inflammatory disorder that requires rapid clinical attention.

  • Comparing early versus delayed initiation of etoposide in patients with severe sporadic HLH
  • Assessing whether treatment timing can change the progression of organ failures in intensive care

Overall, the research aims to support more effective and timely treatment strategies for patients facing this serious pathological condition.

Site Overview

assignment
2
connected trials
corporate_fare
1
sponsor
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
1
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Other Trials in Centre Hospitalier Universitaire de la Guadeloupe

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Comparison of Early Versus Delayed Etoposide Initiation in Severe Sporadic Hemophagocytic Lymphohistiocytosis in Intensive Care: A Randomized TrialAssistance Publique Hopitaux De ParisPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Etoposide2Unknown

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.